Arcutis Biotherapeutics, Inc.
USD25.99
-0.77 (-2.89%)
CEO
Todd Franklin Watanabe
IPO Date
2020-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$27.15
Prev. Close
$26.76
Day Low
$25.83
Day High
$27.20
52W Low
$13.06
52W High
$31.77
Market Cap
$3.25B
Volume
0.19M
| 822 |
| $6.52 |
| 17 Jun 2026 | Welgus Howard G. | director | M-Exempt | Acquired | 1,019 | $7.51 |
| 17 Jun 2026 | Welgus Howard G. | director | M-Exempt | Acquired | 2,255 | $8.63 |
| 17 Jun 2026 | Welgus Howard G. | director | S-Sale | Disposed | 4,096 | $24.41 |
| 17 Jun 2026 | Welgus Howard G. | director | S-Sale | Disposed | 635 | $25.67 |
| 17 Jun 2026 | Welgus Howard G. | director | M-Exempt | Disposed | 822 | $6.52 |
| 17 Jun 2026 | Welgus Howard G. | director | M-Exempt | Disposed | 1,019 | $7.51 |
| 17 Jun 2026 | Welgus Howard G. | director | M-Exempt | Disposed | 2,255 | $8.63 |
| 12 Jun 2026 | Heron Patrick J | director: | Disposed | 0 | $0.00 |
| $1,001 - $15,000 |
| 8 Apr 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 13 Jan 2026 | Gilbert Cisneros | Gilbert Cisneros | Sale | $1,001 - $15,000 |
| 15 Oct 2023 | Josh Gottheimer | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 19 May 2023 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 22 Jul 2022 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |